Article metrics

Download PDFPDF

Original research
Clinical outcomes of prexasertib monotherapy in recurrent BRCA wild-type high-grade serous ovarian cancer involve innate and adaptive immune responses

 

Online download statistics by month:

Online download statistics by month: July 2020 to August 2021

AbstractFullPdf
Jul 202018518574
Aug 202015715879
Sep 2020616143
Oct 2020484829
Nov 2020373721
Dec 2020373725
Jan 2021626244
Feb 2021242413
Mar 2021393923
Apr 2021292916
May 2021303026
Jun 2021343423
Jul 2021262621
Aug 2021242423
Total793794460